JPH02180275A - Medicine injection tool having ultrasonic wave oscillation element - Google Patents
Medicine injection tool having ultrasonic wave oscillation elementInfo
- Publication number
- JPH02180275A JPH02180275A JP63333397A JP33339788A JPH02180275A JP H02180275 A JPH02180275 A JP H02180275A JP 63333397 A JP63333397 A JP 63333397A JP 33339788 A JP33339788 A JP 33339788A JP H02180275 A JPH02180275 A JP H02180275A
- Authority
- JP
- Japan
- Prior art keywords
- conduit
- ultrasonic wave
- medicine
- oscillation element
- drugs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 66
- 238000002347 injection Methods 0.000 title claims abstract description 25
- 239000007924 injection Substances 0.000 title claims abstract description 25
- 229940079593 drug Drugs 0.000 title claims description 58
- 230000010356 wave oscillation Effects 0.000 title abstract description 4
- 230000010355 oscillation Effects 0.000 claims description 33
- 238000009792 diffusion process Methods 0.000 abstract description 6
- 239000007788 liquid Substances 0.000 abstract description 5
- 230000002093 peripheral effect Effects 0.000 abstract description 5
- 210000000056 organ Anatomy 0.000 abstract description 3
- 239000006185 dispersion Substances 0.000 abstract 1
- 238000000638 solvent extraction Methods 0.000 abstract 1
- 210000001124 body fluid Anatomy 0.000 description 13
- 239000010839 body fluid Substances 0.000 description 13
- 239000000919 ceramic Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 8
- 230000035515 penetration Effects 0.000 description 7
- 238000002604 ultrasonography Methods 0.000 description 6
- 239000004020 conductor Substances 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000005192 partition Methods 0.000 description 4
- 206010018852 Haematoma Diseases 0.000 description 3
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000003527 fibrinolytic agent Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 229960000103 thrombolytic agent Drugs 0.000 description 2
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- -1 oral preparations Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 229960005356 urokinase Drugs 0.000 description 1
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、人体外からカテーテル又は薬物注入導管を介
して薬物を体内に注入して注入部位に直接超音波振動を
付与し、注入薬物等の拡散、浸透を良好にする薬物注入
具に関するものである。Detailed Description of the Invention [Industrial Application Field] The present invention is a method of injecting a drug into the body from outside the human body through a catheter or a drug injection conduit, applying ultrasonic vibration directly to the injection site, and injecting drugs, etc. This invention relates to a drug injection device that improves the diffusion and penetration of drugs.
人の病気の治療、予防等に外部より薬物を投与する方法
としては、注射剤、経口剤、座剤、経皮投与剤等による
経口、非経口的に投与する方法がある。特に体内に直接
薬物等を注入する方法としては、局所注射、動静脈注射
、血管内カテーテル等を介して体内の目的部位に薬物を
注入する方法がある。Methods for externally administering drugs for the treatment and prevention of human diseases include oral and parenteral administration using injections, oral preparations, suppositories, transdermal preparations, and the like. In particular, methods for directly injecting drugs and the like into the body include methods of injecting drugs into a target site within the body via local injection, arteriovenous injection, intravascular catheter, and the like.
これらの手段によって薬物を直接体内に注入する場合は
、注入された薬物が体内の組織へ拡散浸透しにくいもの
もあり、それを良好にするために従来は化学的な手法に
よるものが主であった。When drugs are directly injected into the body by these means, it may be difficult for the injected drugs to diffuse into tissues within the body, and in order to improve this, chemical methods have traditionally been used. Ta.
本発明者は先にカテーテルによる薬物投与の際、薬物の
拡散、浸透を良くするため超音波を用いることに着目し
、カテーテルに接続している基部より超音波による振動
を与える血管洗浄機を発明した(特開昭56−5207
1号公報)
〔発明が解決しようとする課題〕
本発明は上記従来の技術において、カテーテルによる薬
物注入の場合、カテーテルにより血管内に注入された薬
物の血管内留置物への拡販、浸透を良好にするため超音
波を利用する方法においては、カテーテルの先端に超音
波を伝達する際、超音波発振機が体外に有り、カテーテ
ルの先端より遠い位習にあるため、途中での超音波工不
ルギ−の減衰があり充分な効果を奏することは困難であ
った。The present inventor first focused on the use of ultrasound to improve the diffusion and penetration of drugs when administering drugs through catheters, and invented a blood vessel cleaning machine that applies ultrasonic vibrations from the base connected to the catheter. (Unexamined Japanese Patent Publication No. 56-5207)
(Publication No. 1) [Problems to be Solved by the Invention] The present invention solves the above-mentioned conventional technology by improving sales expansion and penetration of the drug injected into the blood vessel by the catheter into the intravascular indwelling device in the case of drug injection using a catheter. In the method of using ultrasound to transmit ultrasound to the tip of the catheter, the ultrasound oscillator is located outside the body and is located far from the tip of the catheter, so there is no need for ultrasound processing during the process. It was difficult to achieve a sufficient effect due to the attenuation of 100 lbs.
本発明者はカテーテルによる薬物等注入の際、血管内に
注入された薬物等が血管内留置物への拡散、浸透を良好
にするため超音波を利用する方法を更に研究を行った結
果、超音波発振素子をカテーテルの体内挿入部の先端に
付け、その発振機を体外に位置する基部に取付け、この
発振機と発振素子を電気的に接合することによって、薬
物の注入局所での拡販、浸透が極めて良好に行われるこ
とを見出し、更にこれをカテーテルのみならず、体内に
挿入する器具に適用することによって、利用範囲の広い
薬物注入器具を提供する本発明を完成した。The present inventor conducted further research on a method of using ultrasound to improve the diffusion and penetration of drugs, etc. injected into blood vessels into intravascular indwelling objects when injecting drugs, etc. using a catheter. By attaching a sound wave oscillation element to the tip of the catheter's body-inserted section, attaching the oscillator to the base located outside the body, and electrically connecting the oscillator and oscillation element, it is possible to increase sales and penetration of drugs at the injection site. The present invention has been completed, which provides a drug injection device with a wide range of uses by applying this to not only catheters but also devices inserted into the body.
本発明は、薬物等の供給部並びに超音波発振機又は超音
波発振機に接続するコネクターを備えた基部の先端に超
音波発振素子を備えた導管を接合し、この超音波発振素
子と超音波発振機とを電気的に接合してなる超音波発振
素子付き薬物注入具である。The present invention connects a conduit equipped with an ultrasonic oscillation element to the tip of a base equipped with a supply part for drugs, an ultrasonic oscillator, or a connector connected to an ultrasonic oscillator, and connects this ultrasonic oscillation element to an ultrasonic This is a drug injection device with an ultrasonic oscillation element that is electrically connected to an oscillator.
本発明に使用する先端に導管を接合した薬物注入具は、
中央に薬物等の流通路並びに、その開放部を薬物等の供
給口として有する基部、その基部の供給口の反対側の先
端に、薬物等の流通路に対応する流通路を中央に有する
金属、ゴム、プラスチックなどの中空細管で形成した導
管を接合したもので、一般に胃、腸1食道、気管、血管
などに使用する他、直接体のm織に薬物を注入する薬物
注入具として用いることができる。The drug injection device with a conduit connected to the tip used in the present invention is as follows:
A base having a distribution channel for drugs, etc. in the center and an opening thereof as a supply port for drugs, etc.; a metal having a distribution channel corresponding to the distribution channel for drugs, etc. in the center at the tip opposite to the supply port of the base; It is a conduit made of hollow thin tubes such as rubber or plastic, and is generally used for the stomach, intestines, esophagus, trachea, blood vessels, etc., and can also be used as a drug injection device to directly inject drugs into the body's tissues. can.
本発明に使用する発振素子は、導管の径と略同径、約1
〜lQmmの円柱形又は中央に透孔を有する円筒形セラ
ミック発振素子又は同形状に成形したソフトタイプのフ
ィルム発振素子が好適に使用することができる。The oscillation element used in the present invention has approximately the same diameter as the conduit, approximately 1
A cylindrical ceramic oscillation element having a diameter of ~1Q mm or a cylindrical ceramic oscillation element having a through hole in the center, or a soft type film oscillation element molded into the same shape can be suitably used.
なお、発振素子の中央に透孔を有する発振素子を使用す
る場合は、この透孔を注入薬物等の流入口としてもよく
、また、体内液の排出口としてもよい。なお、排出口と
する場合は、基部及び導管内に円筒状の隔壁を設け、中
央路及び外周路の2室に分け、基部及び導管の中央路及
び外周路を対応するように連接し、中央路を体内液の流
通路とし、外周路を薬物等の流通路とする。そして、発
振素子の透孔を導管の体内液の流通路に連接する。Note that when an oscillation element having a through hole in the center of the oscillation element is used, this through hole may be used as an inlet for injected drugs or the like, or as an outlet for body fluids. In addition, when using it as a discharge port, install a cylindrical partition inside the base and the conduit, divide it into two chambers, a central passage and an outer circumferential passage, connect the central passage and the outer circumferential passage of the base and the conduit in a corresponding manner, and connect the central passage and outer circumferential passage of the base and the conduit. The channel is used as a flow path for body fluids, and the outer circumferential path is used as a flow path for drugs and the like. Then, the through hole of the oscillation element is connected to the body fluid flow path of the conduit.
導管に、この発振素子と近接する部位に薬物等の流出孔
を設ける。The conduit is provided with an outflow hole for drugs, etc. in a region close to the oscillation element.
中央に透孔を有しない円筒形の発振素子を使用する場合
は、導管本体に、この発振素子と近接する部位に薬物等
の流出孔を設ける必要がある。When using a cylindrical oscillation element that does not have a through hole in the center, it is necessary to provide an outflow hole for drugs, etc. in the conduit body at a portion adjacent to the oscillation element.
上記の導管の先端に設けられた超音波発振素子は、本発
明の注入具の基部に備えられた超音波発振機又は開発F
i機に接続されるコネクターと導線により接合されてい
る。この導線は導管の部材中に埋めて保持してもよく、
その内部表面に接着させて保持させてもよい。The ultrasonic oscillation element provided at the tip of the conduit is the ultrasonic oscillator provided at the base of the injection device of the present invention or the ultrasonic oscillation element provided at the tip of the conduit.
It is connected by a conductor to the connector connected to the i-machine. The conductor may be embedded and retained within the conduit member;
It may also be retained by adhering to its internal surface.
本発明は上記のように構成されているがら、超音波を発
振する素子が常に薬物等の標的部位に最も近い位置にお
いて振動を与えつつ薬物等が注入される。従って、標的
部位の組織に対し、拡散浸透が極めて良好に行われる。Although the present invention is configured as described above, the drug or the like is injected while the ultrasonic oscillating element always vibrates at a position closest to the target site of the drug or the like. Therefore, the diffusion penetration into the tissue of the target site is extremely good.
また、発振素子の超音波の強さの調節、超音波周波数の
調節は、本発明の注入具に設置又は接続されている超音
波発振機により適宜調節することができる。従って、そ
の選択により限定部位の大きさを制御することができる
。Further, the intensity of the ultrasonic waves of the oscillation element and the ultrasonic frequency can be adjusted as appropriate using an ultrasonic oscillator installed or connected to the injection tool of the present invention. Therefore, the size of the restricted region can be controlled by selection.
次に本発明の薬物注入具の例を添付図面により説明する
。Next, an example of the drug injection device of the present invention will be explained with reference to the accompanying drawings.
例1
第1図に示すように、中央部に薬物等の流通路5を貫通
し、その開放部を薬物等の供給口6とした注入具基部1
に超音波発振機8に接続するコネクター7を備え、この
基部1の供給口6の反対側の先端に、直径1〜10mm
の薬物等の流通路4を形成した中空プラスチック製導管
2を接合し、この導管2の先端に導管と適合する直径の
高さ1〜10mmの円筒形セラミック発振素子3を接合
する。この円筒形セラミック発振素子3には、その中央
部に直径0.5〜9mlTlの透孔9を穿設しである。Example 1 As shown in Fig. 1, a base 1 of an injector has a distribution passage 5 for drugs, etc. passed through the central part, and the open part thereof is a supply port 6 for drugs, etc.
is equipped with a connector 7 to be connected to an ultrasonic oscillator 8, and a connector 7 with a diameter of 1 to 10 mm is provided at the tip opposite to the supply port 6 of the base 1.
A hollow plastic conduit 2 having a flow path 4 for a drug or the like is joined to the tip of the conduit 2, and a cylindrical ceramic oscillation element 3 having a diameter and a height of 1 to 10 mm that matches the conduit is joined to the tip of the conduit 2. This cylindrical ceramic oscillation element 3 is provided with a through hole 9 having a diameter of 0.5 to 9 ml Tl in the center thereof.
セラミック発振素子3とコネクター7は導線10により
接続する。そして、この導線10は導管2の内壁面又は
壁内に保持する。The ceramic oscillation element 3 and the connector 7 are connected by a conductive wire 10. This conducting wire 10 is held on the inner wall surface or within the wall of the conduit 2.
一方、コネクター7は超音波発振機8に接続する。On the other hand, the connector 7 is connected to an ultrasonic oscillator 8.
例2
本例は、例1の薬物注入具において、発振素子3に透孔
を有しない場合である。Example 2 This example is a case where the oscillation element 3 does not have a through hole in the drug injection device of Example 1.
従って、発振素子3及び導管2の先端以外は例1と同様
でる。Therefore, the components other than the oscillation element 3 and the tip of the conduit 2 are the same as in Example 1.
第2図は発振素子3及び導92の先端部を表す。FIG. 2 shows the oscillation element 3 and the tip of the conductor 92.
第2図に示すように、セラミック発振素子3は透孔を有
せず、導管の下部のセラミック発振素子3と接合する部
位のやや上方に透孔11を設ける。As shown in FIG. 2, the ceramic oscillation element 3 does not have a through hole, but a through hole 11 is provided slightly above the portion of the lower part of the conduit where it is joined to the ceramic oscillation element 3.
例3
第3図に示すように、注入具基部1内を隔壁12によっ
て、中央路と外周路とに分け、中央路を体内液排出路1
3とし、外周路を薬物等の流通路5とする。そして、こ
の各流通路の開放部を体内液排出口14及び薬物等の供
給口6とした。この注入具基部1に超音波発振機8に接
続するコネクター7を設け、体内液排出口14、薬物等
の供給口6の反対側の先端に、基部と同様に導管の隔壁
16によっ′ζ中央路と外周路とに分け、中央路を導管
2の体内液流通路15.外周路を薬物等の流通路4とす
る導管2を基部1の体内液流通路13及び薬物等の流通
路5と導管2の体内液流通路15及び薬物等の流通路4
が連結するように各通路を接合する。Example 3 As shown in FIG. 3, the inside of the injection device base 1 is divided into a central passage and an outer peripheral passage by a partition wall 12, and the central passage is divided into a body fluid drainage passage 1.
3, and the outer circumferential path is used as a distribution path 5 for drugs, etc. The open portions of each of the flow passages were defined as a body fluid discharge port 14 and a drug supply port 6. A connector 7 connected to an ultrasonic oscillator 8 is provided at the base 1 of the injector, and a connector 7 connected to the ultrasonic oscillator 8 is provided at the tip opposite to the body fluid discharge port 14 and the supply port 6 for drugs, etc. The central passage is divided into a central passage and a peripheral passage, and the central passage is connected to the body fluid flow passage 15 of the conduit 2. The conduit 2 whose outer peripheral path is the distribution path 4 for drugs, etc. is connected to the body fluid distribution path 13 of the base 1, the distribution path 5 for drugs, etc., the body fluid distribution path 15 of the conduit 2, and the distribution path 4 for drugs, etc.
Connect each passage so that they are connected.
導管2の他端に透孔9を設けた円筒形セラミック発振素
子3の内周が導管2の体内液流通路15と、セラミック
発振素子3の外周が導管2の外周とそれぞれ一致するよ
うに結合させ、導管2とセラミック発振素子3の結合部
のやや上部の導管壁に透孔11を穿設し薬物等の流出口
とする。The inner circumference of the cylindrical ceramic oscillation element 3 with a through hole 9 provided at the other end of the conduit 2 is connected to the body fluid flow passage 15 of the conduit 2, and the outer circumference of the ceramic oscillation element 3 is connected to the outer circumference of the conduit 2, respectively. Then, a through hole 11 is bored in the wall of the conduit slightly above the joint between the conduit 2 and the ceramic oscillation element 3 to serve as an outlet for drugs and the like.
なお、セラミック発振素子3とコネクター7は導線10
により接続する。そして、この導線10は導管2の内壁
面に接着し保持する。Note that the ceramic oscillation element 3 and the connector 7 are connected to a conductor 10.
Connect by. The conducting wire 10 is then adhered to and held on the inner wall surface of the conduit 2.
一方、コネクター7は超音波発振機8に接続する。On the other hand, the connector 7 is connected to an ultrasonic oscillator 8.
本島は、薬物等の注入と共に器管中の液状物を、同液中
に浮遊する凝集物を超音波により破砕、溶解させ外部に
排出することができる。Honjima is capable of injecting drugs, etc., and using ultrasonic waves to crush and dissolve any aggregates floating in the liquid in the organ and discharge them to the outside.
C発胡の効果〕
本発明は薬物等の組織内への注入を超音波振動を与えつ
つ行うから、薬物等の拡散、浸透が著しく良好になり、
例えば、心臓冠動脈の血栓症の治療に、本発明の薬物注
入具を血栓近くまで入れ、溶解剤(ウロキナーゼ等)を
注入ずれば血栓溶解剤の溶解率は著しく増強され、血流
再開までの時間も短縮され、臨床成績は改善される。Effects of C-Facing] In the present invention, drugs, etc. are injected into tissues while applying ultrasonic vibrations, so the diffusion and penetration of drugs, etc. is significantly improved.
For example, in the treatment of thrombosis in the coronary arteries of the heart, if the drug injection device of the present invention is inserted close to the thrombus and a dissolving agent (urokinase, etc.) is injected, the dissolution rate of the thrombolytic agent will be significantly enhanced, and it will take time until blood flow resumes. The duration of treatment is also shortened, and clinical outcomes are improved.
また、脳出血部の血腫の中に本発明の薬物注入具、特に
実施例3の構造のものを使用すると、血栓溶解剤を注入
すると同時に超音波照射により血腫を溶解して導管より
吸入し外部に排出することができ、脳出血の治療適応が
著しく広められる効果を有する。In addition, when the drug injection device of the present invention, especially the structure of Example 3, is used in a hematoma in a cerebral hemorrhage site, the thrombolytic agent is injected, the hematoma is simultaneously dissolved by ultrasonic irradiation, and the hematoma is inhaled through a conduit and delivered to the outside. It has the effect of greatly expanding its therapeutic potential for cerebral hemorrhage.
第1図は本発明の実施例1の薬物注入具の断面図、第2
図は同実施例2の導管と超音波振動素子の結合部分を示
した斜視図、第3図は同実施例3の薬物注入具の断面図
を示す。
l:薬物注入具基部 2:導管
3;超音波発振素子 4;導管の薬物等の流3m路5・
基部の薬物等の流血路
6;薬物等の供給口 7:コネクター
8;超音波発振機 9:超音波発振素子の透孔10:
導線 11:導管の透孔12:基部の隔壁
13:基部の体内液流通路14:体内液排出口
15:導管の体内液流通路16:導管の隔壁FIG. 1 is a sectional view of a drug injection device according to Example 1 of the present invention, and FIG.
The figure is a perspective view showing the connecting portion of the conduit and the ultrasonic vibration element of Example 2, and FIG. 3 is a sectional view of the drug injection device of Example 3. l: Base of drug injector 2: Conduit 3; Ultrasonic oscillation element 4; 3m flow path for drugs, etc. in the conduit 5.
Blood flow path 6 for drugs, etc. at the base; Supply port for drugs, etc. 7: Connector 8; Ultrasonic oscillator 9: Through hole 10 of the ultrasonic oscillator element:
Conductor wire 11: Conduit through hole 12: Base partition
13: Body fluid flow path at the base 14: Body fluid outlet
15: Body fluid flow path of the conduit 16: Partition of the conduit
Claims (1)
機と接続するコネクターを備えた基部の先端に超音波発
振素子を備えた導管を接合し、この超音波発振素子と超
音波発振機とを電気的に結合してなることを特徴とする
超音波発振素子付き薬物注入具。1. A conduit equipped with an ultrasonic oscillation element is joined to the tip of the base that is equipped with a supply part for drugs, etc. and an ultrasonic oscillator or a connector for connecting to the ultrasonic oscillator, and the ultrasonic oscillator and the ultrasonic oscillator are connected to each other. 1. A drug injection device with an ultrasonic oscillation element, characterized in that the device is electrically coupled with the ultrasonic oscillation element.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63333397A JPH02180275A (en) | 1988-12-29 | 1988-12-29 | Medicine injection tool having ultrasonic wave oscillation element |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63333397A JPH02180275A (en) | 1988-12-29 | 1988-12-29 | Medicine injection tool having ultrasonic wave oscillation element |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH02180275A true JPH02180275A (en) | 1990-07-13 |
JPH0445187B2 JPH0445187B2 (en) | 1992-07-24 |
Family
ID=18265662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63333397A Granted JPH02180275A (en) | 1988-12-29 | 1988-12-29 | Medicine injection tool having ultrasonic wave oscillation element |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH02180275A (en) |
Cited By (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5315998A (en) * | 1991-03-22 | 1994-05-31 | Katsuro Tachibana | Booster for therapy of diseases with ultrasound and pharmaceutical liquid composition containing the same |
US6277110B1 (en) | 1998-02-25 | 2001-08-21 | Advanced Cardiovascular Systems, Inc. | Method of crimping an intravascular stent onto a balloon catheter |
WO2004073522A1 (en) * | 2003-02-20 | 2004-09-02 | Nihon University | Catheter sensor for measuring hardness |
US6921371B2 (en) | 2002-10-14 | 2005-07-26 | Ekos Corporation | Ultrasound radiating members for catheter |
US6958040B2 (en) | 2001-12-28 | 2005-10-25 | Ekos Corporation | Multi-resonant ultrasonic catheter |
US6979293B2 (en) | 2001-12-14 | 2005-12-27 | Ekos Corporation | Blood flow reestablishment determination |
US7141044B2 (en) | 2001-12-11 | 2006-11-28 | Ekos Corporation | Alternate site gene therapy |
US7201737B2 (en) | 2004-01-29 | 2007-04-10 | Ekos Corporation | Treatment of vascular occlusions using elevated temperatures |
US7220239B2 (en) | 2001-12-03 | 2007-05-22 | Ekos Corporation | Catheter with multiple ultrasound radiating members |
WO2008024532A1 (en) * | 2006-08-21 | 2008-02-28 | Boston Scientific Scimed, Inc. | Ultrasound catheter |
US7341569B2 (en) | 2004-01-30 | 2008-03-11 | Ekos Corporation | Treatment of vascular occlusions using ultrasonic energy and microbubbles |
US7914509B2 (en) | 1997-05-01 | 2011-03-29 | Ekos Corporation | Ultrasound catheter |
US7976483B2 (en) | 1997-05-01 | 2011-07-12 | Ekos Corporation | Ultrasound assembly with increased efficacy |
US7993308B2 (en) | 2003-04-22 | 2011-08-09 | Ekos Corporation | Ultrasound enhanced central venous catheter |
US8852166B1 (en) | 2002-04-01 | 2014-10-07 | Ekos Corporation | Ultrasonic catheter power control |
US9107590B2 (en) | 2004-01-29 | 2015-08-18 | Ekos Corporation | Method and apparatus for detecting vascular conditions with a catheter |
JP2016515012A (en) * | 2013-03-14 | 2016-05-26 | エコス コーポレーション | Method and apparatus for delivering a drug to a target location |
US9757145B2 (en) | 2009-08-07 | 2017-09-12 | Ulthera, Inc. | Dissection handpiece and method for reducing the appearance of cellulite |
US10092742B2 (en) | 2014-09-22 | 2018-10-09 | Ekos Corporation | Catheter system |
US10220122B2 (en) | 2007-10-09 | 2019-03-05 | Ulthera, Inc. | System for tissue dissection and aspiration |
US10232196B2 (en) | 2006-04-24 | 2019-03-19 | Ekos Corporation | Ultrasound therapy system |
US10271866B2 (en) | 2009-08-07 | 2019-04-30 | Ulthera, Inc. | Modular systems for treating tissue |
US10531888B2 (en) | 2009-08-07 | 2020-01-14 | Ulthera, Inc. | Methods for efficiently reducing the appearance of cellulite |
US10548659B2 (en) | 2006-01-17 | 2020-02-04 | Ulthera, Inc. | High pressure pre-burst for improved fluid delivery |
US10603066B2 (en) | 2010-05-25 | 2020-03-31 | Ulthera, Inc. | Fluid-jet dissection system and method for reducing the appearance of cellulite |
US10656025B2 (en) | 2015-06-10 | 2020-05-19 | Ekos Corporation | Ultrasound catheter |
US11096708B2 (en) | 2009-08-07 | 2021-08-24 | Ulthera, Inc. | Devices and methods for performing subcutaneous surgery |
US11337725B2 (en) | 2009-08-07 | 2022-05-24 | Ulthera, Inc. | Handpieces for tissue treatment |
US11458290B2 (en) | 2011-05-11 | 2022-10-04 | Ekos Corporation | Ultrasound system |
US11672553B2 (en) | 2007-06-22 | 2023-06-13 | Ekos Corporation | Method and apparatus for treatment of intracranial hemorrhages |
US11925367B2 (en) | 2007-01-08 | 2024-03-12 | Ekos Corporation | Power parameters for ultrasonic catheter |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56109653A (en) * | 1980-02-04 | 1981-08-31 | Olympus Optical Co | Pneumoperitoneum device |
JPS58209336A (en) * | 1982-05-31 | 1983-12-06 | アロカ株式会社 | Ultrasonic diagnostic apparatus |
JPS63177866A (en) * | 1986-09-18 | 1988-07-22 | ポール ジー ヨック | Apparatus used in cannulation of blood vessel |
-
1988
- 1988-12-29 JP JP63333397A patent/JPH02180275A/en active Granted
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56109653A (en) * | 1980-02-04 | 1981-08-31 | Olympus Optical Co | Pneumoperitoneum device |
JPS58209336A (en) * | 1982-05-31 | 1983-12-06 | アロカ株式会社 | Ultrasonic diagnostic apparatus |
JPS63177866A (en) * | 1986-09-18 | 1988-07-22 | ポール ジー ヨック | Apparatus used in cannulation of blood vessel |
Cited By (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6585678B1 (en) | 1991-03-22 | 2003-07-01 | Ekos Corporation | Booster for therapy of disease with ultrasound and pharmaceutical IDLIQU composition containing the same |
USRE36939E (en) * | 1991-03-22 | 2000-10-31 | Ekos Corporation | Composition for therapy of diseases with ultrasonic and pharmaceutical liquid composition containing the same |
US5315998A (en) * | 1991-03-22 | 1994-05-31 | Katsuro Tachibana | Booster for therapy of diseases with ultrasound and pharmaceutical liquid composition containing the same |
US7976483B2 (en) | 1997-05-01 | 2011-07-12 | Ekos Corporation | Ultrasound assembly with increased efficacy |
US8690818B2 (en) | 1997-05-01 | 2014-04-08 | Ekos Corporation | Ultrasound catheter for providing a therapeutic effect to a vessel of a body |
US7914509B2 (en) | 1997-05-01 | 2011-03-29 | Ekos Corporation | Ultrasound catheter |
US6277110B1 (en) | 1998-02-25 | 2001-08-21 | Advanced Cardiovascular Systems, Inc. | Method of crimping an intravascular stent onto a balloon catheter |
US7828762B2 (en) | 2001-12-03 | 2010-11-09 | Ekos Corporation | Catheter with multiple ultrasound radiating members |
US10080878B2 (en) | 2001-12-03 | 2018-09-25 | Ekos Corporation | Catheter with multiple ultrasound radiating members |
US9415242B2 (en) | 2001-12-03 | 2016-08-16 | Ekos Corporation | Catheter with multiple ultrasound radiating members |
US7220239B2 (en) | 2001-12-03 | 2007-05-22 | Ekos Corporation | Catheter with multiple ultrasound radiating members |
US10926074B2 (en) | 2001-12-03 | 2021-02-23 | Ekos Corporation | Catheter with multiple ultrasound radiating members |
US7727178B2 (en) | 2001-12-03 | 2010-06-01 | Ekos Corporation | Catheter with multiple ultrasound radiating members |
US7141044B2 (en) | 2001-12-11 | 2006-11-28 | Ekos Corporation | Alternate site gene therapy |
US6979293B2 (en) | 2001-12-14 | 2005-12-27 | Ekos Corporation | Blood flow reestablishment determination |
US6958040B2 (en) | 2001-12-28 | 2005-10-25 | Ekos Corporation | Multi-resonant ultrasonic catheter |
US8852166B1 (en) | 2002-04-01 | 2014-10-07 | Ekos Corporation | Ultrasonic catheter power control |
US9943675B1 (en) | 2002-04-01 | 2018-04-17 | Ekos Corporation | Ultrasonic catheter power control |
US7509715B2 (en) | 2002-10-14 | 2009-03-31 | Ekos Corporation | Method of manufacturing ultrasound radiating members for a catheter |
US6921371B2 (en) | 2002-10-14 | 2005-07-26 | Ekos Corporation | Ultrasound radiating members for catheter |
WO2004073522A1 (en) * | 2003-02-20 | 2004-09-02 | Nihon University | Catheter sensor for measuring hardness |
US7993308B2 (en) | 2003-04-22 | 2011-08-09 | Ekos Corporation | Ultrasound enhanced central venous catheter |
US9107590B2 (en) | 2004-01-29 | 2015-08-18 | Ekos Corporation | Method and apparatus for detecting vascular conditions with a catheter |
US7201737B2 (en) | 2004-01-29 | 2007-04-10 | Ekos Corporation | Treatment of vascular occlusions using elevated temperatures |
US7341569B2 (en) | 2004-01-30 | 2008-03-11 | Ekos Corporation | Treatment of vascular occlusions using ultrasonic energy and microbubbles |
US7648478B2 (en) | 2004-01-30 | 2010-01-19 | Ekos Corporation | Treatment of vascular occlusions using ultrasonic energy and microbubbles |
US10548659B2 (en) | 2006-01-17 | 2020-02-04 | Ulthera, Inc. | High pressure pre-burst for improved fluid delivery |
US11058901B2 (en) | 2006-04-24 | 2021-07-13 | Ekos Corporation | Ultrasound therapy system |
US10232196B2 (en) | 2006-04-24 | 2019-03-19 | Ekos Corporation | Ultrasound therapy system |
WO2008024532A1 (en) * | 2006-08-21 | 2008-02-28 | Boston Scientific Scimed, Inc. | Ultrasound catheter |
US11925367B2 (en) | 2007-01-08 | 2024-03-12 | Ekos Corporation | Power parameters for ultrasonic catheter |
US11672553B2 (en) | 2007-06-22 | 2023-06-13 | Ekos Corporation | Method and apparatus for treatment of intracranial hemorrhages |
US10220122B2 (en) | 2007-10-09 | 2019-03-05 | Ulthera, Inc. | System for tissue dissection and aspiration |
US11337725B2 (en) | 2009-08-07 | 2022-05-24 | Ulthera, Inc. | Handpieces for tissue treatment |
US10485573B2 (en) | 2009-08-07 | 2019-11-26 | Ulthera, Inc. | Handpieces for tissue treatment |
US10531888B2 (en) | 2009-08-07 | 2020-01-14 | Ulthera, Inc. | Methods for efficiently reducing the appearance of cellulite |
US10271866B2 (en) | 2009-08-07 | 2019-04-30 | Ulthera, Inc. | Modular systems for treating tissue |
US11096708B2 (en) | 2009-08-07 | 2021-08-24 | Ulthera, Inc. | Devices and methods for performing subcutaneous surgery |
US9757145B2 (en) | 2009-08-07 | 2017-09-12 | Ulthera, Inc. | Dissection handpiece and method for reducing the appearance of cellulite |
US10603066B2 (en) | 2010-05-25 | 2020-03-31 | Ulthera, Inc. | Fluid-jet dissection system and method for reducing the appearance of cellulite |
US11213618B2 (en) | 2010-12-22 | 2022-01-04 | Ulthera, Inc. | System for tissue dissection and aspiration |
US11458290B2 (en) | 2011-05-11 | 2022-10-04 | Ekos Corporation | Ultrasound system |
JP2019088870A (en) * | 2013-03-14 | 2019-06-13 | エコス コーポレーション | Method and apparatus for drug delivery to target site |
JP2016515012A (en) * | 2013-03-14 | 2016-05-26 | エコス コーポレーション | Method and apparatus for delivering a drug to a target location |
US10507320B2 (en) | 2014-09-22 | 2019-12-17 | Ekos Corporation | Catheter system |
US10092742B2 (en) | 2014-09-22 | 2018-10-09 | Ekos Corporation | Catheter system |
US10656025B2 (en) | 2015-06-10 | 2020-05-19 | Ekos Corporation | Ultrasound catheter |
US11740138B2 (en) | 2015-06-10 | 2023-08-29 | Ekos Corporation | Ultrasound catheter |
Also Published As
Publication number | Publication date |
---|---|
JPH0445187B2 (en) | 1992-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH02180275A (en) | Medicine injection tool having ultrasonic wave oscillation element | |
US5197946A (en) | Injection instrument with ultrasonic oscillating element | |
US6723064B2 (en) | Ultrasonic catheter drug delivery method and device | |
US5267985A (en) | Drug delivery by multiple frequency phonophoresis | |
US6113570A (en) | Method of removing thrombosis in fistulae | |
US6585678B1 (en) | Booster for therapy of disease with ultrasound and pharmaceutical IDLIQU composition containing the same | |
US5628730A (en) | Phoretic balloon catheter with hydrogel coating | |
JP5086240B2 (en) | Dual needle feeding system | |
EP0753322B1 (en) | Catheter for injecting fluid medication into an arterial wall | |
US10350110B2 (en) | Dual lumen surgical work tip for placing chemicals to dissolve cataracts | |
US20160030725A1 (en) | Method and apparatus for treatment of intracranial hemorrhages | |
EP1230951A1 (en) | External ultrasound apparatus for enhancement of thrombolysis | |
JP2018519060A5 (en) | ||
US20060036191A1 (en) | Ultrasonic system for treatment of otolaryngologic diseases and ultrasonic instrument for these purposes and ultrasonic otolaryngologic set. | |
KR102247333B1 (en) | Medical conduit to enable bidirectional fluid flow | |
US9987026B2 (en) | Medical instrument | |
JP2010509944A (en) | Ultrasonic fluid delivery device and method for delivering fluid to the body using ultrasonic energy | |
JPH03275075A (en) | Liquid medicine injection port | |
JP2908503B2 (en) | Chemical injection port | |
WO2007102933A2 (en) | Composition for ultrasound therapy and pharmaceutical liquid composition containing the same | |
JPH04295362A (en) | Controller for ultrasonic therapy | |
TWI221422B (en) | Quasi-T shaped catheter for chemotherapy | |
JPH09202736A (en) | Hemostatic agent | |
Gus' kov | Comparative analysis of various techniques of prostatic drainage in patients with chronic obstructive prostatitis |